|
|
Lorena: Dialysis Treatment Sparks Unlikely Friendship - KWTX |
|
LORENA (May 12, 2015) Before January of 2009, Randy Williams was a normal man. He would commute from Lorena to Austin to work, and would umpire on his days off.
Today, he is living on disability claims and has been on a kidney waiting list for over a year.
After multiple tests doctors discovered Williams, 56, had autonomic dysfunction. That issue led to kidney failure.
For the past two years, Williams has had dialysis treatments three times a week for four-and-a-half hours.
Even though the dialysis treatments have taken a toll on Williams' body, one thing has kept him pushing through the treatments. A newfound friendship.
Terry Key, 26, of Troy was diagnosed with End Stage Renal Failure in 2011. He is also undergoing dialysis treatments.
Even though Williams is 30 years Key's senior, their hopes for longer lives are one in the same.
"When you go to dialysis there's like fifty chairs...it's like one big family," says Williams.
Both Williams and Key know tomorrow isn't promised. Their search for donors is made more urgent when their big family gets smaller.
"I see the same people every Monday, Wednesday, and Friday. In the last two years I've also probably seen five or six people that were no longer there because they passed away," says Williams.
About 123,000 people are waiting for organs and about 100,000 of those are waiting for kidneys.
|
|
|
Disclosure Restrictions Frequent in Medical Malpractice Settlements - Renal and Urology News |
|
HCV increases mortality among patients with CKD - Healio |
|
Veterans with chronic kidney disease and hepatitis C virus infection were found to have an increased rate of mortality, risk of lower kidney function and incidence of loss of kidney function vs. veterans without the infection, according to new study data.
“Hepatitis C affects 4 million Americans [and] previous studies have not established unanimously whether hepatitis C is associated with the development and progression of chronic kidney disease,” Csaba P. Kovesdy, MD, director of the Clinical Outcomes and Clinical Trials Program at Memphis VA Medical Center in Tenn., told Healio.com/Hepatology. “[The study] examined the association of hepatitis C infection with mortality, with the development of new onset chronic kidney disease, with end stage renal disease and with the speed of loss of kidney function in over 1 million U.S. veterans. We found that hepatitis C infection was associated with a significantly increased risk of all these end points.”
Csaba P. Kovesdy
Kovesdy and colleagues analyzed data from 100,518 veterans with chronic kidney disease (CKD) positive for HCV and 920,531 US veterans without HCV with normal baseline estimated glomerular filtration rate (eGFR). The incidence of decreased kidney function was defined as an eGFR < 60 mL/min/1.73 m? and a 25% decrease in eGFR.
Using multivariable adjusted models, the researchers found that HCV was associated with a 2.2-fold higher mortality (fully adjusted HR = 2.17; 95% CI, 2.13-2.21), a 15% higher incident rate of decreased kidney function (adjust HR = 1.15; 95% CI, 1.12-1.17), a 22% higher risk of steeper slopes of eGFR (adjusted OR = 1.22; 95% CI, 1.19-1.26) and a 98% higher hazard of end-stage renal disease (ESRD; adjusted HR = 1.98; 95% CI, 1.81-2.16), according to the research.
“The strongest association was with higher mortality and ESRD,” Kovesdy said.
In a competing-risk regression analysis, HCV-positive status was also found to be associated with an increased risk of new-onset eGFR < 60 mL/min/1.73 m? and an increased risk of ESRD. Viremic patients also had a 10% higher risk for new-onset eGFR < 60 mL/min/1.73 m? (HR = 1.1; 95% CI, 1.05-1.16), 62% higher risk for ESRD (HR = 1.62; 95% CI, 1.26-2.07) and a 23% higher risk for deterioration of kidney function (HR = 1.23; 95% CI, 1.14-1.33) compared with patients who were negative for HCV antibody.
“Our results suggest that treatment of hepatitis C may be beneficial in lowering mortality and both in preventing the development of new onset CKD and the progression of established CKD,” Kovesdy said. “The emergence of new therapeutic agents for hepatitis C now offer the potential to treat hepatitis C even in patients with CKD, which makes the results concerning progression of CKD especially interesting. These hypotheses will need to be tested in clinical trials.” – by Melinda Stevens
Disclosures:Molnar and Kovesdy report no relevant financial disclosures. Please see the full study for a list of all other authors’ relevant financial disclosures.
|
|
Aultman to open new dialysis center in Navarre - The-review |
|
Aultman Hospital is opening a new dialysis center this June. The dialysis center will be located on the Altercare of Navarre for Rehabilitation & Nursing Care Inc. campus. Aultman will celebrate the new dialysis center opening with a community open house from 4-6 p.m. on June 9.
“When health care providers collaborate to meet the community’s needs, it’s a ‘win’ for everyone,” said Aultman Chief Nursing Officer Anne Gunther, DNP, RN, NE-BC. “We invite community members to tour the new facility and learn more about our services.”
The Aultman Dialysis Center of Navarre is located at 517 Park St. in Navarre.
"Altercare of Navarre is grateful that the residents of Navarre and the surrounding communities are now offered a safe and comfortable dialysis experience,” said Eileen D’Alessandris, administrator of Altercare of Navarre. “We support the Aultman Dialysis Center and its service to our patients.”
Aultman Dialysis Center of Navarre provides patients with a convenient, high-quality dialysis facility by offering in-center hemodialysis. Dialysis is a common treatment method for people with kidney failure, which is also known as end stage renal disease (ESRD). With early detection of underlying causes of ESRD, you may be able to delay the start of dialysis. Ways to be proactive include:
- Knowing your family’s medical history.
- Keeping regular medical checkups.
- Know your kidney numbers.
- Taking medication prescribed for high blood pressure and diabetes.
The primary causes of renal failure are high blood pressure and diabetes. Individuals who reach stage five chronic kidney disease will need dialysis or a kidney transplant for treatment. For more information about the services available at Aultman Dialysis Center of Navarre or for scheduling availability, please call 330-791-7791.
In addition to the Aultman Dialysis Center of Navarre, Aultman also offers an outpatient dialysis center located at 2912 Tuscarawas St. W. in Canton. Home dialysis units are also available. Call 330-458-0150 to learn more.
|
|
Factors Predicting Non-Diagnostic Renal Mass Biopsies ID'd - Renal and Urology News |
May 12, 2015
When patients with specific tumor-related features were excluded from biopsy, the non-diagnostic rate dropped from 14.7 to 8.7%.
Investigators have identified criteria that predict which renal mass biopsies are likely to be non-diagnostic, according to a recently published report. Excluding patients with these criteria from biopsy decreased the non-diagnostic rate from 14.7% to 8.7%.
These factors include renal masses with cystic features, radiologic enhancement less than 20 HU, small size (less than 4 cm), and a skin-to-tumor distance of 13 cm or greater.
For the study, investigators from the University of Wisconsin School of Medicine and Public Health in Madison reviewed the records and pre-biopsy imaging for 525 patients at their institution who had renal tumors 7 cm or less.
Following biopsy, 14.7% of patients overall and 17.4% of patients with renal masses 4 cm or smaller had non-diagnostic findings, according to results published in The Journal of Urology (2015;193:1899-1904). For those undergoing a repeat biopsy, the rate of non-diagnostic findings was similar at 20.8%. Radiologist or pathologist experience was ruled out as a contributing factor.
“In patients with tumors at a distance of 13 cm or greater from the body surface the rate of non-diagnostic biopsy was 27%, likely reflecting the increased technical difficulty of maneuvering the biopsy needle in deep tissue and the decreased visualization of the needle and tumor when using US guidance for these biopsies,” the authors wrote.
Tiny tumors, cystic masses with small areas of malignant cells, and lack of radiological enhancement also present targeting challenges.
Source
- Prince, J, et al. The Journal of Urology; doi: 10.1016/j.juro.2014.12.021.
|
|
|
|
|
<< Start < Prev 131 132 133 134 135 136 137 138 139 140 Next > End >>
|
|
Page 133 of 2630 |
Log in to explore the world's most comprehensive database of dialysis centres for free! 
Professional dialysis recruitment
